BioPlus Acquisition, a blank check company targeting life sciences, filed on Tuesday with the SEC to raise up to $220 million in an initial public offering.

The New York, NY-based company plans to raise $220 million by offering 22 million units at $10 per unit. Each unit containIPOs Feed


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.